With socio-economic development and incremental pressure on people, the number of people suffering from depression has increased dramatically, bringing serious costs to society and families
Sunday: 09:00 - 17:00 Stay informed with expert insights, IV tips, and the latest advancements in IV to support your health journey
The 4.5 mg dose produced 10.8% reduction (11.5 kg average)
Systemic side effects from the tiny amount of benzyl alcohol in each dose are exceedingly rare in adults
It isn't approved for treating obesity, but during tirzepatide diabetes trials, researchers noted people who got tirzepatide lost much more weight than those on standard diabetes therapy
It's non-invasive, outpatient, and requires no recovery time